Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | HRAS |
Variant | G13D |
Impact List | missense |
Protein Effect | loss of function |
Gene Variant Descriptions | HRAS G13D is hotspot mutation that lies within the GTP nucleotide binding region of the Hras protein (UniProt.org). G13D results in decreased Hras GTPase activity and loss of response to GTPase-activating proteins, leading to activation of downstream signaling and senescence in cell culture (PMID: 24224811, PMID: 21850009). |
Associated Drug Resistance | |
Category Variants Paths |
HRAS mutant HRAS act mut HRAS G13D HRAS mutant HRAS G13X HRAS G13D |
Transcript | NM_005343.4 |
gDNA | chr11:g.534285C>T |
cDNA | c.38G>A |
Protein | p.G13D |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_176795.4 | chr11:g.534285C>T | c.38G>A | p.G13D | RefSeq | GRCh38/hg38 |
NM_001130442.3 | chr11:g.534285C>T | c.38G>A | p.G13D | RefSeq | GRCh38/hg38 |
NM_176795 | chr11:g.534285C>T | c.38G>A | p.G13D | RefSeq | GRCh38/hg38 |
NM_005343.4 | chr11:g.534285C>T | c.38G>A | p.G13D | RefSeq | GRCh38/hg38 |
NM_001130442 | chr11:g.534285C>T | c.38G>A | p.G13D | RefSeq | GRCh38/hg38 |
NM_001130442.2 | chr11:g.534285C>T | c.38G>A | p.G13D | RefSeq | GRCh38/hg38 |
NM_176795.5 | chr11:g.534285C>T | c.38G>A | p.G13D | RefSeq | GRCh38/hg38 |
NM_005343 | chr11:g.534285C>T | c.38G>A | p.G13D | RefSeq | GRCh38/hg38 |
NM_005343.3 | chr11:g.534285C>T | c.38G>A | p.G13D | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05638698 | Phase II | Balstilimab + QS21 + TG01 QS21 + TG01 | Tg01 Vaccine / Qs-21 Stimulon™ With Or Without Balstilimab As Maintenance Therapy Following Adjuvant Chemotherapy In Patients With Resected Pancreatic Cancer (TESLA) | Active, not recruiting | USA | 0 |